TFF completes dosing in Phase Ib clinical study for asthma drug
The firm is investigating viability of voriconazole inhalation powder, intended to treat and prevent invasive pulmonary aspergillosis in asthma patients.
Archives for November 15, 2021
Biohaven wraps patient enrollment for ALS clinical trial arm
The pharma company has completed enrollment of amyotrophic lateral sclerosis patients in its study investigating drugs like verdiperstat, an oral treatment.